Hiroshi Mizuuchi

1.3k total citations
34 papers, 1.1k citations indexed

About

Hiroshi Mizuuchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hiroshi Mizuuchi has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Hiroshi Mizuuchi's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Hiroshi Mizuuchi is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Hiroshi Mizuuchi collaborates with scholars based in Japan, United Kingdom and United States. Hiroshi Mizuuchi's co-authors include Tetsuya Mitsudomi, Kenichi Suda, Vikas Jaitely, Sudaxshina Murdan, Alastair J. Florence, Kazuto Nishio, Yoshihiko Maehara, Kenji Tomizawa, Katsuaki Sato and Yukiya Hashimoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hiroshi Mizuuchi

32 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hiroshi Mizuuchi

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Mizuuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Mizuuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Mizuuchi more than expected).

Fields of papers citing papers by Hiroshi Mizuuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Mizuuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Mizuuchi. The network helps show where Hiroshi Mizuuchi may publish in the future.

Co-authorship network of co-authors of Hiroshi Mizuuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Mizuuchi. A scholar is included among the top collaborators of Hiroshi Mizuuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Mizuuchi. Hiroshi Mizuuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Case of Tension Pneumomediastinum Treated With Mediastinal Drainage Using a Semi-flexible Fiberscope via a Subxiphoid Approach 2024 ·Cureus ·Yuji Matsumoto, Hiroshi Mizuuchi, (unknown), Masahiro Hata, (unknown)	0
2	Liver metastases 2 years after resection of a very-low-risk duodenal gastrointestinal stromal tumor: a case report 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Shoji Hiroshige, Shun Nakamura, Junichi Takahashi, Kazuhito Sakata, Hiroshi Mizuuchi, Taro Oba, (unknown), Kentaro Iwaki, Hideya Takeuchi, Kiyoshi Kajiyama, Kengo Fukuzawa	1
3	CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer 2018 ·Molecular Cancer Therapeutics ·Kenichi Suda, Isao Murakami, Hui Yu, Jihye Kim, Aik Choon Tan, Hiroshi Mizuuchi, Leslie Rozeboom, Kim Ellison, Christopher J. Rivard, Tetsuya Mitsudomi, Fred R. Hirsch	39
4	Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non–Small Cell Lung Cancer: Double-Edged Sword of DDR2 2016 ·Clinical Cancer Research ·Masato Terashima, Yosuke Togashi, Katsuaki Sato, Hiroshi Mizuuchi, Kazuko Sakai, Kenichi Suda, Yu Nakamura, Eri Banno, Hidetoshi Hayashi, Marco A. De Velasco, Yoshihiko Fujita, Shuta Tomida, Tetsuya Mitsudomi, Kazuto Nishio	15
5	Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression 2016 ·PLoS ONE ·Katsuaki Sato, Kenichi Suda, Shigeki Shimizu, Kazuko Sakai, Hiroshi Mizuuchi, Kenji Tomizawa, Toshiki Takemoto, Kazuto Nishio, Tetsuya Mitsudomi	13
6	Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells 2016 ·Lung Cancer ·(unknown), Kenichi Suda, Hiroshi Mizuuchi, Yoshihisa Kobayashi, Katsuaki Sato, Masato Chiba, Masaki Shimoji, Kenji Tomizawa, Toshiki Takemoto, Tetsuya Mitsudomi	42
7	MEK inhibitors against MET-amplified non-small cell lung cancer 2016 ·International Journal of Oncology ·Masato Chiba, Yosuke Togashi, Shuta Tomida, Hiroshi Mizuuchi, Yu Nakamura, Eri Banno, Hidetoshi Hayashi, Masato Terashima, Marco A. De Velasco, Kazuko Sakai, Yoshihiko Fujita, Tetsuya Mitsudomi, Kazuto Nishio	27
8	EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs 2015 ·Clinical Cancer Research ·Yoshihisa Kobayashi, Yosuke Togashi, Yasushi Yatabe, Hiroshi Mizuuchi, Park Jangchul, (unknown), Masaki Shimoji, Katsuaki Sato, Kenichi Suda, Kenji Tomizawa, (unknown), Toyoaki Hida, Kazuto Nishio, Tetsuya Mitsudomi	164
9	Collateral Chemoresistance to Anti-Microtubule Agents in a Lung Cancer Cell Line with Acquired Resistance to Erlotinib 2015 ·PLoS ONE ·Hiroshi Mizuuchi, Kenichi Suda, Katsuaki Sato, Shuta Tomida, Yoshihiko Fujita, Yoshihisa Kobayashi, Yoshihiko Maehara, Yoshitaka Sekido, Kazuto Nishio, Tetsuya Mitsudomi	13
10	An activating ALK gene mutation in ALK IHC-positive/FISH-negative non-small cell lung cancer 2015 ·Annals of Oncology ·Yosuke Togashi, Hiroshi Mizuuchi, Kazuko Sakai, Eri Banno, Hidetoshi Hayashi, Marco A. De Velasco, Yoshihiko Fujita, (unknown), Tetsuya Mitsudomi, Kazuto Nishio	1
11	Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer 2015 ·Lung Cancer ·Kenichi Suda, Isao Murakami, Kazuko Sakai, Kenji Tomizawa, Hiroshi Mizuuchi, Katsuaki Sato, Kazuto Nishio, Tetsuya Mitsudomi	30
12	Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer 2015 ·Scientific Reports ·Kenichi Suda, Isao Murakami, Kazuko Sakai, Hiroshi Mizuuchi, Shigeki Shimizu, Katsuaki Sato, Kenji Tomizawa, Shuta Tomida, Yasushi Yatabe, Kazuto Nishio, Tetsuya Mitsudomi	74
13	MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor 2015 ·Lung Cancer ·Yosuke Togashi, Hiroshi Mizuuchi, Shuta Tomida, Masato Terashima, Hidetoshi Hayashi, Kazuto Nishio, Tetsuya Mitsudomi	38
14	CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation 2014 ·Lung Cancer ·Kenichi Suda, Hiroshi Mizuuchi, Isao Murakami, Hidetaka Uramoto, Fumihiro Tanaka, Katsuaki Sato, Toshiki Takemoto, Takuya Iwasaki, Yoshitaka Sekido, Yasushi Yatabe, Tetsuya Mitsudomi	10
15	The insulin‐like growth factor 1 receptor causes acquired resistance to erlotinib in lung cancer cells with the wild‐type epidermal growth factor receptor 2014 ·International Journal of Cancer ·Kenichi Suda, Hiroshi Mizuuchi, Katsuaki Sato, Toshiki Takemoto, Takuya Iwasaki, Tetsuya Mitsudomi	46
16	Acquired resistance mechanisms to tyrosine kinase inhibitors in lung cancer with activating epidermal growth factor receptor mutation—diversity, ductility, and destiny 2012 ·Cancer and Metastasis Reviews ·Kenichi Suda, Hiroshi Mizuuchi, Yoshihiko Maehara, Tetsuya Mitsudomi	121
17	Current-stimulated release of solutes solubilized in water-immiscible room temperature ionic liquids (RTILs) 2010 ·Journal of drug targeting ·Vikas Jaitely, Hiroshi Mizuuchi, Alexander T. Florence	12
18	Room temperature ionic liquids and their mixtures: Potential pharmaceutical solvents 2008 ·European Journal of Pharmaceutical Sciences ·Hiroshi Mizuuchi, Vikas Jaitely, Sudaxshina Murdan, Alastair J. Florence	188
19	Intramuscular absorption and biodistribution of dexamethasone from non-aqueous emulsions in the rat 2006 ·International Journal of Pharmaceutics ·(unknown), J. Turton, Hiroshi Mizuuchi, Alexander T. Florence	28
20	Transport Characteristics of Diphenhydramine in Human Intestinal Epithelial Caco-2 Cells: Contribution of pH-Dependent Transport System 1999 ·Journal of Pharmacology and Experimental Therapeutics ·Hiroshi Mizuuchi, Toshiya Katsura, Hideyuki Saito, Yukiya Hashimoto, Ken‐ichi Inui	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact